Abstract:Background The tumor microenvironment (TME) has a central role in the oncogenesis of osteosarcomas. The composition of the TME is essential for the interaction between tumor and immune cells. The aim of this study was to establish a prognostic index (TMEindex) for osteosarcoma based on the TME, from which estimates about patient survival and individual response to immune checkpoint inhibitor (ICI) therapy can be deduced. Methods Based on osteosarcoma samples from the Therapeutically Applicable Research to Generate Effective Treatments (TARGET) database, the ESTIMATE algorithm was used to estimate ImmuneScore and StromalScore. Combined differentially expressed gene analysis, weighted gene co-expression network analyses, the Least Absolute Shrinkage and Selection Operator regression and stepwise regression to construct the TMEindex. The prognostic role of TMEindex was validated in three independent datasets. The molecular and immune characteristics of TMEindex and the impact on immunotherapy were then comprehensively investigated. The expression of TMEindex genes in different cell types and its effects on osteosarcoma cells were explored by scRNA-Seq analysis and molecular biology experiments. Results Fundamental is the expression of MYC, P4HA1, RAMP1 and TAC4. Patients with high TMEindex had worse overall survival, recurrence-free survival, and metastasis-free survival. TMEindex is an independent prognostic factor in osteosarcoma. TMEindex genes were mainly expressed in malignant cells. The knockdown of MYC and P4HA1 significantly inhibited the proliferation, invasion and migration of osteosarcoma cells. A high TME index is related to the MYC, mTOR, and DNA replication-related pathways. In contrast, a low TME index is related to immune-related signaling pathways such as the inflammatory response. The TMEindex was negatively correlated with ImmuneScore, StromalScore, immune cell infiltration, and various immune-related signature scores. Patients with a higher TMEindex had an immune-cold TME and higher invasiveness. Patients with a low TME index were more likely to respond to ICI therapy and achieve clinical benefit. In addition, the TME index correlated with response to 29 oncologic drugs. Conclusions The TMEindex is a promising biomarker to predict the prognosis of patients with osteosarcoma and their response to ICI therapy, and to distinguish the molecular and immune characteristics.

Determination of the Apoptotic Index in Osteosarcoma Tissue and Its Relationship with Patients Prognosis

Clinical significance of determination of apoptosis in human osteosarcoma

Expressions of P53, C-Myc, BCL-2 and Apoptotic Index in Human Osteosarcoma and Their Correlations with Prognosis of Patients.

Identification of a Programmed Cell Death-related Signature for Prediction of Osteosarcoma

[Apoptosis-Related Gene Expression and Its Clinical Significance of Human Osteosarcoma].

Three Hematological Indexes That May Serve As Prognostic Indicators in Patients with Primary, High-Grade, Appendicular Osteosarcoma

Expression of Apoptosis Related Genes in Osteosarcoma Cells and Their Clinical Significance

Identification of Tumorigenicity-Associated Genes in Osteosarcoma Cell Lines Based on Bioinformatic Analysis and Experimental Validation.

Construction and validation of a novel apoptosis-associated prognostic signature related to osteosarcoma metastasis and immune infiltration

Overexpression of Hypoxia-Inducible Factor-1 Alpha in Human Osteosarcoma: Correlation with Clinicopathological Parameters and Survival Outcome

A Tumor Microenvironment-Based Prognostic Index for Osteosarcoma

The correlation of inhibitor of apoptosis protein Survivin and the stages,histopathology of osteosarcoma

Expression of XIAP in Osteosarcoma Tissues and Its Clinical Significance

High serum alkaline phosphatase cooperating with MMP-9 predicts metastasis and poor prognosis in patients with primary osteosarcoma in Southern China

Expression and Clinical Significance of Bcl-2, Cox-2, HSPs and P53 in Patients with Osteosarcoma

[Preliminary Study on Relationship among Apoptosis and Related Gene, Prognosis of Lung Cancer].

Predicting Chemosensitivity in Osteosarcoma Prior to Chemotherapy: an Investigational Study of Biomarkers with Immunohistochemistry

In Situ Labeling Apotosis in Breast Cancer As Related to Prognosis

Prognostic Significance of Programmed Death Ligand 1 Expression and Tumor-Infiltrating Lymphocytes in Axial Osteosarcoma

Prognostic Significance of Apoptosis in Synovial Sarcoma: Correlation with Clinicopathologic Parameters, Cell Proliferative Activity, and Expression of Apoptosis-Related Proteins

Prognostic Significance of Preoperative Serum ALP and LDH in Osteosarcoma Patients